Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,804,000 | 1,959,300 | 1,599,800 | 984,000 | 1,046,000 |
| Depreciation Amortization | 463,000 | 442,600 | 408,100 | 329,800 | 297,300 |
| Income taxes - deferred | -143,000 | 110,500 | 202,600 | 50,900 | -152,200 |
| Accounts receivable | -271,000 | -241,700 | -139,900 | -188,900 | -44,100 |
| Other Working Capital | -77,000 | 171,500 | -285,400 | -352,600 | 323,300 |
| Other Operating Activity | 1,048,000 | 403,600 | 293,000 | 767,000 | 361,200 |
| Operating Cash Flow | $2,824,000 | $2,845,800 | $2,078,200 | $1,590,200 | $1,831,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,002,000 | -1,210,800 | 129,000 | 220,000 | -467,000 |
| PPE Investments | -452,000 | -424,600 | -380,400 | -386,400 | -439,700 |
| Net Acquisitions | -108,000 | -30,900 | -1,900 | -4,057,600 | N/A |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -41,000 | 15,500 | 3,700 | -157,700 | -118,800 |
| Investing Cash Flow | $-1,603,000 | $-1,650,800 | $-249,600 | $-4,381,700 | $-1,025,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 90,000 | -19,500 | -172,300 | 2,353,500 | -152,200 |
| Debt Issued | N/A | N/A | 5,600 | 7,000 | 8,700 |
| Debt Repayment | -2,000 | N/A | -10,300 | -11,100 | -10,200 |
| Common Stock Issued | 334,000 | 241,400 | 155,900 | 120,500 | 148,700 |
| Common Stock Repurchased | -511,000 | -880,500 | -418,500 | -25,600 | N/A |
| Dividend Paid | -405,000 | -351,500 | -304,200 | -278,800 | -240,700 |
| Financing Cash Flow | $-494,000 | $-1,010,100 | $-743,800 | $2,165,500 | $-245,700 |
| Exchange Rate Effect | -89,000 | -61,300 | -25,400 | 6,400 | 2,200 |
| Beginning Cash Position | 1,594,000 | 1,470,100 | 410,700 | 1,030,300 | 467,800 |
| End Cash Position | 2,232,000 | 1,593,700 | 1,470,100 | 410,700 | 1,030,300 |
| Net Cash Flow | $638,000 | $123,600 | $1,059,400 | $-619,600 | $562,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,824,000 | 2,845,800 | 2,078,200 | 1,590,200 | 1,831,500 |
| Capital Expenditure | -452,000 | -424,600 | -380,400 | -386,400 | -439,700 |
| Free Cash Flow | 2,372,000 | 2,421,200 | 1,697,800 | 1,203,800 | 1,391,800 |